Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension
NCT00168363 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 207
Last updated 2011-05-30
Summary
This Study will evaluate the safety and efficacy of brimonidine in patients with glaucoma or ocular hypertension
Conditions
Interventions
- DRUG
-
brimonidine
Sponsors & Collaborators
-
Allergan
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-01-31
- Primary Completion
- 2006-08-31
- Completion
- 2006-08-31
More Related Trials
-
A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
NCT00538304 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
NCT00332384 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
NCT00332436 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
NCT01830140 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension
NCT01068964 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
NCT02339584 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension
NCT01687426 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
NCT00332345 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
NCT02061683 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination
NCT00961649 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients
NCT00651612 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00061529 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
NCT00652106 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Alphagan on Retinal Blood Flow Autoregulation and Motion Detection in Patients With Normal Pressure Glaucoma
NCT01105065 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension
NCT00652496 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00314158 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat Glaucoma
NCT07209410 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00326092 ·Status: COMPLETED ·Phase: PHASE2
-
Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension
NCT01309204 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma
NCT00809848 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%
NCT01426867 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension
NCT00332072 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
NCT01110499 ·Status: COMPLETED ·Phase: PHASE2
-
An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects
NCT00811564 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Brimonidine on Corneal Thickness
NCT01250236 ·Status: UNKNOWN